SLNO logo

Soleno Therapeutics (SLNO) Total Expenses

Annual Total Expenses

$38.67 M
+$13.56 M+54.01%

31 December 2023

SLNO Total Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Expenses

$79.33 M
+$56.10 M+241.50%

30 September 2024

SLNO Quarterly Total Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SLNO Total Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+54.0%+747.5%
3 y3 years+21.0%+925.7%
5 y5 years+181.6%+1199.5%

SLNO Total Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+54.0%at high+1199.9%
5 y5 yearsat high+181.6%at high+1199.9%
alltimeall timeat high+975.0%at high>+9999.0%

Soleno Therapeutics Total Expenses History

DateAnnualQuarterly
Sept 2024
-
$79.33 M(+241.5%)
June 2024
-
$23.23 M(+0.7%)
Mar 2024
-
$23.07 M(+79.9%)
Dec 2023
$38.67 M(+54.0%)
$12.83 M(+37.0%)
Sept 2023
-
$9.36 M(+12.6%)
June 2023
-
$8.31 M(+1.7%)
Mar 2023
-
$8.17 M(+31.5%)
Dec 2022
$25.11 M(-22.2%)
$6.21 M(+1.8%)
Sept 2022
-
$6.10 M(-1.0%)
June 2022
-
$6.16 M(-7.1%)
Mar 2022
-
$6.63 M(+4.8%)
Dec 2021
$32.26 M(+1.0%)
$6.33 M(-18.2%)
Sept 2021
-
$7.74 M(-3.9%)
June 2021
-
$8.05 M(-20.6%)
Mar 2021
-
$10.14 M(+29.8%)
Dec 2020
$31.95 M(+37.7%)
$7.82 M(+10.4%)
Sept 2020
-
$7.08 M(-15.2%)
June 2020
-
$8.35 M(-4.0%)
Mar 2020
-
$8.70 M(+26.4%)
Dec 2019
$23.20 M(+68.9%)
$6.88 M(+12.7%)
Sept 2019
-
$6.11 M(+12.2%)
June 2019
-
$5.44 M(+14.0%)
Mar 2019
-
$4.77 M(+34.2%)
Dec 2018
$13.73 M
$3.56 M(-2.5%)
DateAnnualQuarterly
Sept 2018
-
$3.65 M(+4.9%)
June 2018
-
$3.48 M(+14.2%)
Mar 2018
-
$3.05 M(+12.6%)
Dec 2017
$9.68 M(+16.3%)
$2.71 M(+2.9%)
Sept 2017
-
$2.63 M(-11.4%)
June 2017
-
$2.97 M(+116.2%)
Mar 2017
-
$1.37 M(-25.1%)
Dec 2016
$8.32 M(-33.7%)
$1.83 M(-6.9%)
Sept 2016
-
$1.97 M(-14.3%)
June 2016
-
$2.30 M(-51.2%)
Mar 2016
-
$4.71 M(+25.7%)
Dec 2015
$12.55 M(+143.2%)
$3.75 M(+14.5%)
Sept 2015
-
$3.27 M(+4.3%)
June 2015
-
$3.14 M(+28.3%)
Mar 2015
-
$2.45 M(+32.6%)
Dec 2014
$5.16 M(+34.1%)
$1.85 M(+39.5%)
Sept 2014
-
$1.32 M(+1.2%)
June 2014
-
$1.31 M(+91.1%)
Mar 2014
-
$684.00 K(+22.2%)
Dec 2013
$3.85 M(+6.9%)
$559.80 K(-43.6%)
Sept 2013
-
$993.00 K(-15.6%)
June 2013
-
$1.18 M(+5.1%)
Mar 2013
-
$1.12 M
Dec 2012
$3.60 M
-

FAQ

  • What is Soleno Therapeutics annual total expenses?
  • What is the all time high annual total expenses for Soleno Therapeutics?
  • What is Soleno Therapeutics annual total expenses year-on-year change?
  • What is Soleno Therapeutics quarterly total expenses?
  • What is the all time high quarterly total expenses for Soleno Therapeutics?
  • What is Soleno Therapeutics quarterly total expenses year-on-year change?

What is Soleno Therapeutics annual total expenses?

The current annual total expenses of SLNO is $38.67 M

What is the all time high annual total expenses for Soleno Therapeutics?

Soleno Therapeutics all-time high annual total expenses is $38.67 M

What is Soleno Therapeutics annual total expenses year-on-year change?

Over the past year, SLNO annual total expenses has changed by +$13.56 M (+54.01%)

What is Soleno Therapeutics quarterly total expenses?

The current quarterly total expenses of SLNO is $79.33 M

What is the all time high quarterly total expenses for Soleno Therapeutics?

Soleno Therapeutics all-time high quarterly total expenses is $79.33 M

What is Soleno Therapeutics quarterly total expenses year-on-year change?

Over the past year, SLNO quarterly total expenses has changed by +$69.97 M (+747.51%)